Fraunhofer Institute for Translational Medicine and Pharmacology ITMP, Theodor-Stern-Kai 7, 60596 Frankfurt am Main, Germany.
Pharmazentrum Frankfurt/ZAFES, Institute of Clinical Pharmacology, Goethe University, Theodor-Stern-Kai 7, 60590 Frankfurt am Main, Germany.
Biomolecules. 2021 Oct 19;11(10):1546. doi: 10.3390/biom11101546.
Disturbances in the one-carbon metabolism are often indicated by altered levels of the endogenous amino acid homocysteine (HCys), which is additionally discussed to causally contribute to diverse pathologies. In the first part of the present review, we profoundly and critically discuss the metabolic role and pathomechanisms of HCys, as well as its potential impact on different human disorders. The use of adequate animal models can aid in unravelling the complex pathological processes underlying the role of hyperhomocysteinemia (HHCys). Therefore, in the second part, we systematically searched PubMed/Medline for animal studies regarding HHCys and focused on the potential impact on cognitive performance and decline. The majority of reviewed studies reported a significant effect of HHCys on the investigated behavioral outcomes. Despite of persistent controversial discussions about equivocal findings, especially in clinical studies, the present evaluation of preclinical evidence indicates a causal link between HHCys and cognition-related- especially dementia-like disorders, and points out the further urge for large-scale, well-designed clinical studies in order to elucidate the normalization of HCys levels as a potential preventative or therapeutic approach in human pathologies.
一碳代谢紊乱通常表现为内源性氨基酸同型半胱氨酸(HCys)水平的改变,此外,同型半胱氨酸被认为是导致多种病理的原因。在本综述的第一部分,我们深入而批判性地讨论了 HCys 的代谢作用和病理机制,以及其对不同人类疾病的潜在影响。适当的动物模型的使用可以帮助揭示高同型半胱氨酸血症(HHCys)作用下复杂的病理过程。因此,在第二部分,我们系统地在 PubMed/Medline 上搜索了关于 HHCys 的动物研究,并重点关注其对认知表现和下降的潜在影响。大多数综述研究报告了 HHCys 对所研究的行为结果有显著影响。尽管关于不一致发现的持续争议讨论,尤其是在临床研究中,目前对临床前证据的评估表明,HHCys 与认知相关的疾病之间存在因果关系,尤其是痴呆样疾病,并指出需要进行大规模、精心设计的临床研究,以阐明 HCys 水平的正常化作为预防或治疗人类疾病的潜在方法。